查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424093

羥考酮藥品市場、份額、規模、趨勢、產業分析報告：按藥物類型、按劑型、按分銷管道、按地區、按細分市場、預測，2024-2032年

Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球羥考酮藥物市場預計將達到 82.9 億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

癌症、類風濕性關節炎、腰痛和纖維肌痛等慢性疼痛疾病盛行率的上升是羥考酮市場擴張的主要驅動力。 此外，其他藥物在治療嚴重疼痛方面表現出的反應性增加了對羥考酮藥劑的需求。 此外，這些藥物的有希望的結果以及與緩釋羥考酮藥物製劑相關的益處增加了它們的處方量。 此外，羥考酮藥物的卓越依從性和短給藥間隔的便利性可能會推動未來幾年的市場成長。

此外，緩釋膠囊的推出和成人劇烈疼痛的高盛行率也推動了市場成長。 此外，市場進入者持有的專利數量的增加以及行銷和促銷支出的增加預計將有助於市場成長。 例如，Collegium Pharmaceuticals 的 Xtampza ER 的專利保護期至 2036 年。

羥考酮製劑也推動了市場成長，與其他鴉片類製劑相比，羥考酮製劑顯示出有希望的結果。 此外，隨著藥物傳遞系統的進步，新藥的出現，例如緩釋製劑，可能為羥考酮藥品市場的成長提供長期機會。 羥考酮緩解手術後劇烈疼痛的能力，加上外科手術的增加，預計將支持市場擴張。

羥考酮作為止痛藥物的廣泛接受度以及手術後疼痛管理對羥考酮的需求不斷增長是推動市場成長的因素。 此外，公司對未開發市場監管審批的強烈關注也將對市場成長產生正面影響。 此外，缺乏身體活動、吸煙和肥胖導致越來越多的患者遭受慢性疼痛。 例如，根據世界肥胖聯合會的《2023 年世界肥胖地圖集》報告，預計全球超重或肥胖人數將從 2020 年的 26 億增加到 40 億。 這些需要止痛藥物的肥胖者可能會在預測期內推動市場成長。

羥考酮藥品市場報告重點

長效細分市場因其在改善疼痛管理和減少疼痛強度變化方面的優勢而佔據市場主導地位。

隨著緩釋膠囊的出現，膠囊細分市場預計將以最高複合年增長率擴張。

由於外科手術和住院人數的增加，醫院部門佔據了最大的市場份額。

北美由於羥考酮處方量大和慢性疼痛狀況增加而主導市場。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章研究方法

第 4 章全球羥考酮藥物市場洞察

  • 羥考酮藥品市場 - 通路概況
  • 羥考酮藥物市場動態
    • 促進因素和機會
      • 慢性疼痛發生率的上升預計將支持羥考酮市場的擴張
      • 羥考酮藥物成本的增加為市場成長提供了長期機會
    • 抑制因素和挑戰
      • 羥考酮的多項風險和嚴格監管預計將阻礙市場成長
  • PESTEL 分析
  • 羥考酮藥品市場通路趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球羥考酮藥物市場（依藥物類型）

  • 主要發現
  • 簡介
  • 短效
  • 長效

第 6 章全球羥考酮藥物市場（以劑型）

  • 主要發現
  • 簡介
  • 錠
  • 膠囊
  • 注射

第 7 章全球羥考酮藥品市場（依通路）

  • 主要發現
  • 簡介
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 8 章全球羥考酮藥品市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年羥考酮藥品市場評估（按地區）
  • 羥考酮藥品市場 - 北美
    • 北美：羥考酮藥物市場（以藥物類型），2019-2032 年
    • 北美：羥考酮藥品市場，依通路劃分，2019-2032 年
    • 北美：羥考酮藥品市場，按劑型，2019-2032 年
    • 羥考酮藥品市場 - 美國
    • 羥考酮藥品市場 - 加拿大
  • 羥考酮藥品市場 - 歐洲
    • 歐洲：羥考酮藥物市場（以藥物類型），2019-2032 年
    • 歐洲：羥考酮藥品市場，依通路劃分，2019-2032 年
    • 歐洲：羥考酮藥品市場（按劑型），2019-2032 年
    • 羥考酮藥品市場 - 英國
    • 羥考酮藥品市場 - 法國
    • 羥考酮藥品市場 - 德國
    • 羥考酮藥品市場 - 義大利
    • 羥考酮藥品市場 - 西班牙
    • 羥考酮藥品市場 - 荷蘭
    • 羥考酮藥品市場 - 俄羅斯
  • 羥考酮藥品市場 - 亞太地區
    • 亞太地區：羥考酮藥物市場（以藥物類型），2019-2032 年
    • 亞太地區：羥考酮藥品市場，依通路劃分，2019-2032 年
    • 亞太地區：羥考酮藥品市場，按劑型，2019-2032 年
    • 羥考酮醫藥市場 - 中國
    • 羥考酮藥品市場 - 印度
    • 羥考酮藥品市場 - 馬來西亞
    • 羥考酮藥品市場 - 日本
    • 羥考酮藥品市場 - 印度尼西亞
    • 羥考酮藥品市場－韓國
  • 羥考酮藥品市場 - 中東和非洲
    • 中東和非洲：羥考酮藥物市場（按藥物類型），2019-2032 年
    • 中東和非洲：羥考酮藥品市場，依通路劃分，2019-2032 年
    • 中東和非洲：羥考酮藥品市場，按劑型，2019-2032 年
    • 羥考酮藥品市場 - 沙烏地阿拉伯
    • 羥考酮藥品市場 - 阿拉伯聯合大公國
    • 羥考酮藥品市場 - 以色列
    • 羥考酮藥品市場 - 南非
  • 羥考酮藥品市場 - 拉丁美洲
    • 拉丁美洲：羥考酮藥物市場（以藥物類型），2019-2032 年
    • 拉丁美洲：羥考酮藥品市場，依通路劃分，2019-2032 年
    • 拉丁美洲：羥考酮藥品市場，按劑型，2019-2032 年
    • 羥考酮藥品市場 - 墨西哥
    • 羥考酮藥品市場 - 巴西
    • 羥考酮藥品市場 - 阿根廷

第 9 章競爭態勢

  • 擴張與收購分析
    • 擴大
    • 收購
  • 夥伴關係/協作/協議/揭露

第 10 章公司簡介

  • Acura Pharmaceuticals（U.S.）
  • Alvogen（U.S.）
  • Amneal Pharmaceuticals LLC.（U.S.）
  • Ascent Pharmaceuticals, Inc.（U.S.）
  • Collegium Pharmaceutical（U.S.）
  • Endo International plc（Ireland）
  • Epic Pharma, LLC.（U.S.）
  • Mallinckrodt（Ireland）
  • Mundipharma International（UK）
  • Pfizer Inc.（U.S.）
  • Protega Pharmaceuticals Inc.（U.S.）
  • Rhodes Pharmaceuticals L.P.（U.S.）
  • Sun Pharmaceutical Industries Ltd.（India）
Product Code: PM4347

The global oxycodone drugs market size is expected to reach USD 8.29 billion by 2032, according to a new study by Polaris Market Research. The report "Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising incidence of chronic pain disease such as cancer, rheumatoid arthritis, lower back pain, and fibromyalgia is the primary contributor for the oxycodone market expansion. Moreover, the unresponsiveness shown by other medications for the treatment of severe pain management has increased the demand for oxycodone drugs. Furthermore, promising results of these drugs and benefits associated with the extended release oxycodone drugs has increased its prescription volumes. Additionally, better compliance and convenience of less-frequent dosage intervals offered by oxycodone drugs will fuel the market growth in the coming years.

The advent of extended-release capsules coupled with the high prevalence of severe pain among adults are also propelling the market growth. Moreover, the patents owned by market players coupled with their increasing expenses on marketing and promotion will contribute to the market growth. For instance, Collegium Pharmaceutical's Xtampza ER has patent protection until 2036.

The promising results shown by the oxycodone drugs over other opioid medications is also driving the market growth. Moreover, the advent of new drugs with advancements in drug delivery systems such as extended-release formulations will provide long-term opportunity for the oxycodone drugs market growth. The ability of oxycodone to lower the severe pain after surgery coupled with an increasing number of surgical procedures are expected to support the market expansion.

The widespread acceptance of oxycodone drugs as a pain-relieving medication and growing need for oxycodone for the pain management after surgeries are the factors propelling the market growth. Moreover, the strong focus of companies on the regulatory approvals in untapped markets will positively influence the market growth. Furthermore, lack of physical activities, tobacco usage, and obesity are increasing the number of patients suffering from chronic pain. For instance, according to the World Obesity Atlas 2023 Report by the World Obesity Federation, the number of people with overweight or obesity worldwide is expected to increase to 4.0 billion, from 2.6 billion in 2020. Such obese people requiring pain management medications will drive the market growth during the forecast period.

Oxycodone Drugs Market Report Highlights

The long-acting segment dominated the market, owing to its benefits for improving pain management and reducing pain intensity variations.

The capsules segment is expected to expand at the highest CAGR, owing to the emergence of extended release capsules.

Hospital segment held the largest market share, owing to the increasing number of surgical procedures and rising hospital admissions.

North America dominated the market, owing to the large volume of oxycodone prescriptions and rising incidences of chronic pain diseases.

The market players include Collegium Pharmaceutical, Mundipharma International, Sun Pharmaceutical Industries Ltd., Endo International plc, and Mallinckrodt.

Polaris Market Research has segmented the oxycodone drugs market report based on drug type, dosage form, distribution channel, and region:

Oxycodone Drugs, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Short-acting
  • Long-acting

Oxycodone Drugs, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)

  • Tablet
  • Capsule
  • Injection

Oxycodone Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Oxycodone Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oxycodone Drugs Market Insights

  • 4.1. Oxycodone Drugs Market - Distribution Channel Snapshot
  • 4.2. Oxycodone Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of chronic pain is expected to support the oxycodone market expansion
      • 4.2.1.2. Increasing expenses for oxycodone drugs will provide a long-term opportunity for the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Several risks of oxycodone coupled with strict regulations is expected to hamper the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Oxycodone Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Oxycodone Drugs Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3. Short-acting
    • 5.3.1. Global Oxycodone Drugs Market, by Short-acting, by Region, 2019-2032 (USD Billion)
  • 5.4. Long-acting
    • 5.4.1. Global Oxycodone Drugs Market, by Long-acting, by Region, 2019-2032 (USD Billion)

6. Global Oxycodone Drugs Market, by Dosage Form

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 6.3. Tablet
    • 6.3.1. Global Oxycodone Drugs Market, by Tablet, by Region, 2019-2032 (USD Billion)
  • 6.4. Capsule
    • 6.4.1. Global Oxycodone Drugs Market, by Capsule, by Region, 2019-2032 (USD Billion)
  • 6.5. Injection
    • 6.5.1. Global Oxycodone Drugs Market, by Injection, by Region, 2019-2032 (USD Billion)

7. Global Oxycodone Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Oxycodone Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Oxycodone Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Oxycodone Drugs Market, by Online Pharmacy, By Region, 2019-2032 (USD Billion)

8. Global Oxycodone Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Oxycodone Drugs Market - North America
    • 8.3.1. North America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.3.4. Oxycodone Drugs Market - U.S.
      • 8.3.4.1. U.S.: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.3.5. Oxycodone Drugs Market - Canada
      • 8.3.5.1. Canada: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.4. Oxycodone Drugs Market - Europe
    • 8.4.1. Europe: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.4. Oxycodone Drugs Market - UK
      • 8.4.4.1. UK: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.5. Oxycodone Drugs Market - France
      • 8.4.5.1. France: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.6. Oxycodone Drugs Market - Germany
      • 8.4.6.1. Germany: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.7. Oxycodone Drugs Market - Italy
      • 8.4.7.1. Italy: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.8. Oxycodone Drugs Market - Spain
      • 8.4.8.1. Spain: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.9. Oxycodone Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.10. Oxycodone Drugs Market - Russia
      • 8.4.10.1. Russia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.5. Oxycodone Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.4. Oxycodone Drugs Market - China
      • 8.5.4.1. China: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.5. Oxycodone Drugs Market - India
      • 8.5.5.1. India: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.6. Oxycodone Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.7. Oxycodone Drugs Market - Japan
      • 8.5.7.1. Japan: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.8. Oxycodone Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.9. Oxycodone Drugs Market - South Korea
      • 8.5.9.1. South Korea: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.6. Oxycodone Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.4. Oxycodone Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.5. Oxycodone Drugs Market - UAE
      • 8.6.5.1. UAE: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.6. Oxycodone Drugs Market - Israel
      • 8.6.6.1. Israel: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.7. Oxycodone Drugs Market - South Africa
      • 8.6.7.1. South Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.7. Oxycodone Drugs Market - Latin America
    • 8.7.1. Latin America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.4. Oxycodone Drugs Market - Mexico
      • 8.7.4.1. Mexico: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.5. Oxycodone Drugs Market - Brazil
      • 8.7.5.1. Brazil: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.6. Oxycodone Drugs Market - Argentina
      • 8.7.6.1. Argentina: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Acura Pharmaceuticals (U.S.)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2.Alvogen (U.S.)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Amneal Pharmaceuticals LLC. (U.S.)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Ascent Pharmaceuticals, Inc. (U.S.)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Collegium Pharmaceutical (U.S.)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Endo International plc (Ireland)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Epic Pharma, LLC. (U.S.)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Mallinckrodt (Ireland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Mundipharma International (UK)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pfizer Inc. (U.S.)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Protega Pharmaceuticals Inc. (U.S.)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Rhodes Pharmaceuticals L.P. (U.S.)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sun Pharmaceutical Industries Ltd. (India)
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development

List of Tables

  • Table 1 Global Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 2 Global Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 3 Global Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 6 North America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 7 North America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 10 U.S.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 13 Canada: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 16 Europe: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 18 UK: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 19 UK: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 21 France: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 22 France: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 25 Germany: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 28 Italy: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 31 Spain: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 37 Russia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 42 China: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 43 China: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 45 India: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 46 India: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 52 Japan: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 58 South Korea: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 67 UAE: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 70 Israel: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 73 South Africa: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 76 Latin America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 79 Mexico: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 82 Brazil: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 85 Argentina: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Oxycodone Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Dosage Form
  • Figure 7. Global Oxycodone Drugs Market, by Dosage Form, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Oxycodone Drugs Market, by Drug Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Oxycodone Drugs Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Oxycodone Drugs Market